Search

everythinglearnresearchcommunity

for

Search:↓

Early diagnosis and surgery can improve symptoms of ovarian hyperthecosis in postmenopausal women.

Adipose tissue and eccrine gland displacement are common in certain alopecias but don't help differentiate between them.

Leydig cell tumors can cause high testosterone and symptoms like hair loss in postmenopausal women, but surgery can improve these symptoms.

Androgen levels do not determine the type of PCOS symptoms in young females.

Testosterone can cause acne and male-pattern baldness, affects hair growth in men and women, and makes male skin more sensitive.

A young man with an unusual type of scarring hair loss suggests a possible new variant of a known scalp condition.

Female androgenetic alopecia affects many women, is reversible with treatment like Minoxidil, and has significant psychological impacts.

Finasteride effectively treats enlarged prostate and male baldness, improves symptoms of hirsutism in women, but doesn't work for acne, and may delay prostate cancer progression with few side effects.

Hormone therapy affects hair growth in transgender individuals, with testosterone potentially causing hair loss in trans men and estrogen reducing facial/body hair in trans women; treatment options vary.

Genetics and hormones cause hair loss; finasteride treats it safely.

Men, particularly those with hair loss, are more likely to get the virus, and those with prostate cancer may have milder symptoms. Testosterone's role in the disease is unclear, and the virus doesn't seem to harm male fertility. Women with PCOS might be at higher risk. More research is needed.

The most common causes of hair loss in a Nigerian hospital were discoid lupus erythematosus of the scalp and alopecia areata, and more research is needed to understand and address these issues.

A new treatment may prevent hair loss from chemotherapy by normalizing scalp cell death and reducing inflammation.

The document concludes that treatments like oral anti-androgens, minoxidil, and topical spironolactone can be effective for hair loss in men and women.

Dihydrotestosterone and 5α-Reductase play a role in hair loss and prostate health, and finasteride can increase hair growth in men without affecting sperm production, but it doesn't work for postmenopausal women with hair loss.

Almost half of COVID-19 patients in Makkah, Saudi Arabia experienced increased hair loss, especially women and those with chronic diseases.

Dutasteride is more effective for male pattern baldness than finasteride, and black cohosh extract BNO 1055 is as effective as conjugated estrogens in treating postmenopausal symptoms, with added benefits in reducing sweating and mental symptoms.

Male pattern baldness is often genetic and linked to a hormone, with treatments like finasteride and minoxidil being effective for some men.

Hormones, especially androgens, affect hair growth and can cause hair loss or excess hair in both men and women.

Early male hair loss might signal higher heart disease risk.

Dermoscopy helps diagnose different types of hair loss and may reduce the need for biopsies.

Researchers found a new gene area linked to male-pattern baldness, which, along with another gene, significantly increases the risk of hair loss in men.

Zinc levels are not directly linked to pattern hair loss.

Androgenetic alopecia is a genetic hair loss condition, more severe in men, and can also be caused by hormonal imbalances in women.

Minoxidil use increases facial hair growth in females, more in older users.

Microneedling may be an effective treatment for pattern hair loss.

Finasteride may affect female fertility by altering gene activity.

Moderately high prolactin levels do not cause hair loss in women.

A growth factor cocktail with FGF9 and microneedling effectively increases hair density and diameter in hair loss patients.

Early balding in men might be a male hormonal equivalent of polycystic ovaries syndrome in women.